Dr. George Ioannou
What are the Benefits of a Sustained Virologic Response to DAAs for HCV Infection?
The effectiveness of direct-acting antivirals in eradicating HCV is firmly established and is one of the greatest triumphs of medical therapeutics in the last 20 years. But to what extent does it lead to clinical benefits for patients?Read More
Dr. Renuka Bhattacharya
Region's 1st HCV Heart-Transplant Recipient is Cured
UW Medicine is declaring success with the Pacific Northwest’s first heart-transplant recipient to purposely acquire the hepatitis C virus (HCV) from the donor organ and then have the disease eradicated by antiviral medication.Read More
Continuing Medical Education
State-of-the-Art in Gastroenterology & Hepatology, Saturday, January 26th
This full-day continuing medical education course discusses the latest advances in research and state-of-the-art clinical practices in the fields of gastroenterology and hepatology.Register Today
Dr. Cynthia Ko
AGA Releases New Guideline on Ulcerative Colitis
Most patients with UC have mild-to-moderate disease characterized by periods of activity or remission, but practice variations exist in disease management. A new AGA guideline addresses the medical management of these patients.Read More
Drs. Rachel Issaka & John Inadomi
Don't Take My Colonoscopy Away!
In a recent survey of 308 veterans, more than one-fourth of respondents strongly objected to losing access to the cancer screening late in life, surprising researchers.Read More